US Bancorp’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
NIMC
AIM
GCM
MAM
US Bancorp's CELL Position: Q4 2022 in Review
US Bancorp sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 850 shares — an estimated $2K sold.
US Bancorp first reported a position in CELL in Q2 2022 and held it in 2 quarters. The position peaked at $8K in Q2 2022. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.
- US Bancorp reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- US Bancorp sold 850 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $2K.
- US Bancorp first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 2 quarters.
- US Bancorp's PhenomeX Inc. Common Stock position peaked at $8K in Q2 2022.
- 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.
Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.